Presentation Outline ICHP Annual Meeting September 13-15

Media‐Worthy Trials?
Making Sense out of the Sensationalism
Lara K. Ellinger, PharmD, BCPS
Clinical Assistant Professor, Drug Information Group
University of Illinois at Chicago
I have no actual or potential conflicts of interest in relation to this program.
Objectives
• Describe the methods and key findings of the papers
presented.
• Explain how the WARFASA trial may affect venous
thromboembolism (VTE) prevention strategies.
• Summarize the findings and implications for practice of the
trial that found an increase in cardiovascular death with
azithromycin use.
• Discuss the clinical significance of risk of stroke and
myocardial infarction with use of hormonal contraception.
• Compare and contrast 3 months of rifapentine and
isoniazid with 9 months of isoniazid as treatment options
for latent tuberculosis.
Outline
• Pertinent background
• Study objective
• Methods
• Results
• Critique/clinical implications
8/30/2012
1